HIV/AIDS

Landmark case holds promise for HIV treatment (Dr. Julio Montaner)

A French teenager, in remission from HIV despite stopping treatment yearsago, has “bolstered the scientific case for initiating HIV treatment soon after diagnosis” that will go a long way in effectively fighting the deadly virus, experts have said.

HIV treatment has social, socioeconomic benefits, as well as improved health (BC Centre for Excellence in HIV/AIDS)

While the health benefits of antiretroviral therapy (ART) for HIV are well documented, less is known about possible secondary benefits.

Supportive housing key in battling HIV, study says (BC Centre for Excellence in HIV/AIDS)

Setting up Vancouver’s homeless HIV patients with supportive housing could dramatically increase the number who stick with anti-retroviral drugs that can reduce the disease to undetectable levels and prevent transmission to others, according to a new study presented on Tuesday at an international HIV/AIDS conference.

Opioid Substitution Saves Lives of HIV-Positive Drug Users

The introduction of opioid agonist therapy — also known as methadone maintenance treatment — has led to a dramatic decrease in HIV- and drug-related mortality in HIV-positive injection drug users, researchers report.

Groundbreaking BC research into HIV-AIDS

A major HIV-Aids conference in Vancouver is also a celebration of the ground-breaking BC research that has helped end the world-wide epidemic. Elaine Yong reports.Today’s News Hour on Global BC Health Headlines brought to you by Pharmasave.

Click here to watch more

Start HIV Treatment Without Delay: Study (Dr. Julio Montaner)

A long-standing question in HIV care has been answered: triple-drug therapy should begin as soon as possible.

Dr. Wood talks HIV treatment and prevention

Studies Confirm That Early Drugs Halt AIDS, Prevent Spread (Dr. Julio Montaner)

Two big studies detailed Monday confirm that earlier treatment for the AIDS virus not only keeps people healthy, but prevents them from infecting others.

IAS 2015: START Trial Provides Definitive Evidence of Benefits of Early HIV Treatment (Dr. Julio Montaner)

People who start antiretroviral therapy (ART) immediately after an HIV diagnosis — while their CD4 T-cell count is still high — rather than waiting until it falls below 350 cells/mm3 have a significantly lower risk of illness and death, according to long-awaited findings from the START trial presented at the 8th International AIDS Society Conference this week in Vancouver and published simultaneously in the July 20 advance edition of the New England Journal of Medicine.

HIV-AIDS experts call for governments worldwide to commit to immediate treatment

Experts on HIV-AIDS gathered in Vancouver are calling on political leaders worldwide to take action to help end the global epidemic.

Pages

Subscribe to RSS - HIV/AIDS